Minocycline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avkare, Inc.. The primary component is Minocycline Hydrochloride.
| Product ID | 42291-591_63eb84ae-8780-4c3a-e053-2a91aa0a8dab |
| NDC | 42291-591 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Minocycline |
| Generic Name | Minocycline |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-05-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065131 |
| Labeler Name | AvKARE, Inc. |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Tetracycline-class Drug [EPC],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-05-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065131 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-05-08 |
| Ingredient | Strength |
|---|---|
| MINOCYCLINE HYDROCHLORIDE | 100 mg/1 |
| SPL SET ID: | ad8678de-ee78-d061-ea5f-d2a6b949b0e5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42291-589 | Minocycline | Minocycline |
| 42291-591 | Minocycline | Minocycline |
| 49884-511 | Minocycline | Minocycline |
| 49884-512 | Minocycline | Minocycline |
| 49884-513 | Minocycline | Minocycline |
| 57664-854 | Minocycline | Minocycline Hydrochloride |
| 57664-855 | Minocycline | Minocycline Hydrochloride |
| 57664-856 | Minocycline | Minocycline Hydrochloride |
| 63629-2228 | Minocycline | Minocycline |
| 63629-2229 | Minocycline | Minocycline |
| 69489-201 | AMZEEQ | Minocycline |
| 72356-101 | AMZEEQ | Minocycline |
| 69489-212 | ZILXI | Minocycline |
| 72356-103 | ZILXI | Minocycline |